BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30932370)

  • 1. Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma.
    Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murao N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
    Cancer Med; 2019 May; 8(5):2146-2156. PubMed ID: 30932370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
    Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
    J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis.
    Kolla AM; Vitiello GA; Friedman EB; Sun J; Potdar A; Daou H; Farrow NE; Farley CR; Vetto JT; Han D; Tariq M; Beasley GM; Contreras CM; Lowe M; Zager JS; Osman I; Berman RS; Liebman TN; Stein JA; Lee AY
    Cancer Control; 2021; 28():10732748211053567. PubMed ID: 34752172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.
    Chi Z; Li S; Sheng X; Si L; Cui C; Han M; Guo J
    BMC Cancer; 2011 Feb; 11():85. PubMed ID: 21349197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic analysis of malignant melanoma in Taiwan.
    Chen YJ; Wu CY; Chen JT; Shen JL; Chen CC; Wang HC
    J Am Acad Dermatol; 1999 Dec; 41(6):945-9. PubMed ID: 10570378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.
    Kanaki T; Stang A; Gutzmer R; Zimmer L; Chorti E; Sucker A; Ugurel S; Hadaschik E; Gräger NS; Satzger I; Schadendorf D; Livingstone E
    Eur J Cancer; 2019 Sep; 119():18-29. PubMed ID: 31401470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update.
    Ishihara K; Saida T; Otsuka F; Yamazaki N;
    Int J Clin Oncol; 2008 Feb; 13(1):33-41. PubMed ID: 18307017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
    Huang K; Fan J; Misra S
    J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
    Di Carlo V; Stiller CA; Eisemann N; Bordoni A; Matz M; Curado MP; Daubisse-Marliac L; Valkov M; Bulliard JL; Morrison D; Johnson C; Girardi F; Marcos-Gragera R; Šekerija M; Larønningen S; Sirri E; Coleman MP; Allemani C;
    Br J Dermatol; 2022 Sep; 187(3):364-380. PubMed ID: 35347700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of immune checkpoint inhibitors prolonged overall survival in a Japanese population of advanced malignant melanoma patients: Retrospective single institutional study.
    Nakamura Y; Fujisawa Y; Tanaka R; Maruyama H; Ishitsuka Y; Okiyama N; Watanabe R; Fujimoto M
    J Dermatol; 2018 Nov; 45(11):1337-1339. PubMed ID: 30204266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
    Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Nagarajan P; Curry JL; Ciurea AM; Rubin AI; Hwu WJ; Prieto VG; Aung PP
    Arch Pathol Lab Med; 2021 Aug; 145(8):943-952. PubMed ID: 33290520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study.
    Barreiro-Capurro A; Andrés-Lencina JJ; Podlipnik S; Carrera C; Requena C; Manrique-Silva E; Quaglino P; Tonella L; Jaka A; Richarz N; Rodríguez-Peralto JL; Ortiz P; Boada A; Ribero S; Nagore E; Malvehy J; Puig S
    Eur J Cancer; 2021 Mar; 145():29-37. PubMed ID: 33418234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Patterns of Melanoma in Asians: 11-Year Experience in a Tertiary Referral Center.
    Chan KK; Chan RC; Ho RS; Chan JY
    Ann Plast Surg; 2016 Feb; 77 Suppl 1():S6-S11. PubMed ID: 26808749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
    Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
    J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
    Okami J; Shintani Y; Okumura M; Ito H; Ohtsuka T; Toyooka S; Mori T; Watanabe SI; Date H; Yokoi K; Asamura H; Nagayasu T; Miyaoka E; Yoshino I;
    J Thorac Oncol; 2019 Feb; 14(2):212-222. PubMed ID: 30316011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of acral lentiginous melanoma in the National Cancer Institute of Colombia.
    Duarte CA; Flórez JP; López HG; Meneses MX; de Vries E
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):438-442. PubMed ID: 27518480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and survival in acral lentiginous melanoma.
    Asgari MM; Shen L; Sokil MM; Yeh I; Jorgenson E
    Br J Dermatol; 2017 Aug; 177(2):428-435. PubMed ID: 28432682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
    Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
    JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Melanoma in African-Americans: A Population-Based Clinical Outcomes Study Involving 1106 African-American Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1988-2011).
    Mahendraraj K; Sidhu K; Lau CSM; McRoy GJ; Chamberlain RS; Smith FO
    Medicine (Baltimore); 2017 Apr; 96(15):e6258. PubMed ID: 28403068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
    Kim HJ; Seo JW; Roh MS; Lee JH; Song KH
    J Am Acad Dermatol; 2018 Oct; 79(4):706-713. PubMed ID: 29673774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.